| 1 |
33960104 | Novel CTRP8-RXFP1-JAK3-STAT3 axis promotes Cdc42-dependent actin remodeling for enhanced filopodia formation and motility in human glioblastoma cells. | 2022 Jan |
1 |
| 2 |
34536483 | Tofacitinib Suppresses IL-10/IL-10R Signaling and Modulates Host Defense Responses in Human Macrophages. | 2022 Mar |
1 |
| 3 |
32783069 | Interleukin-17A up-regulates thymic stromal lymphopoietin production by nasal fibroblasts from patients with allergic rhinitis. | 2021 Jan |
1 |
| 4 |
32909045 | The JAK Inhibitor Tofacitinib Rescues Intestinal Barrier Defects Caused by Disrupted Epithelial-macrophage Interactions. | 2021 Mar 5 |
1 |
| 5 |
33165509 | Impaired IFN-γ-dependent STAT3 Activation Is Associated With Dysregulation of Regulatory and Inflammatory Signaling in Monocytes of Ulcerative Colitis Patients. | 2021 May 17 |
1 |
| 6 |
33337450 | STAT3/IL-6 dependent induction of inflammatory response in osteoblast and osteoclast formation in nanoscale wear particle-induced aseptic prosthesis loosening. | 2021 Feb 21 |
2 |
| 7 |
33495807 | Downregulation of miR‑409‑3p suppresses LPS‑induced inflammation in human bronchial epithelial cells through SOCS3/JAK1/STAT3 signaling: The implication for bronchopneumonia. | 2021 Mar |
1 |
| 8 |
33517393 | Mosaic IL6ST variant inducing constitutive GP130 cytokine receptor signaling as a cause of neonatal onset immunodeficiency with autoinflammation and dysmorphy. | 2021 Apr 26 |
2 |
| 9 |
33693775 | Tofacitinib alters STAT3 signaling and leads to endometriosis lesion regression. | 2021 Mar 24 |
4 |
| 10 |
33801973 | EGCG Inhibits Adipose-Derived Mesenchymal Stem Cells Differentiation into Adipocytes and Prevents a STAT3-Mediated Paracrine Oncogenic Control of Triple-Negative Breast Cancer Cell Invasive Phenotype. | 2021 Mar 10 |
1 |
| 11 |
34107055 | Tofacitinib therapy intercepts macrophage metabolic reprogramming instigated by SARS-CoV-2 Spike protein. | 2021 Sep |
1 |
| 12 |
34630419 | Tofacitinib Suppresses Several JAK-STAT Pathways in Rheumatoid Arthritis In Vivo and Baseline Signaling Profile Associates With Treatment Response. | 2021 |
2 |
| 13 |
31448433 | Preferential Inhibition of JAK1 Relative to JAK3 by Upadacitinib: Exposure-Response Analyses of Ex Vivo Data From 2 Phase 1 Clinical Trials and Comparison to Tofacitinib. | 2020 Feb |
1 |
| 14 |
32561292 | Role of JAK-STAT signaling in the pathogenic behavior of fibroblast-like synoviocytes in rheumatoid arthritis: Effect of the novel JAK inhibitor peficitinib. | 2020 Sep 5 |
1 |
| 15 |
32927842 | Tofacitinib and Baricitinib Are Taken up by Different Uptake Mechanisms Determining the Efficacy of Both Drugs in RA. | 2020 Sep 10 |
1 |
| 16 |
30332965 | Targeting Upstream Kinases of STAT3 in Human Medulloblastoma Cells. | 2019 |
1 |
| 17 |
30357932 | JAK1/3 inhibition preserves epidermal morphology in full-thickness 3D skin models of atopic dermatitis and psoriasis. | 2019 Feb |
2 |
| 18 |
28752178 | Inhibitory effect of JAK inhibitor on mechanical stress-induced protease expression by human articular chondrocytes. | 2017 Nov |
1 |
| 19 |
25398374 | The JAK inhibitor tofacitinib suppresses synovial JAK1-STAT signalling in rheumatoid arthritis. | 2015 Jun |
1 |
| 20 |
25057499 | Hepatic stellate cell coculture enables sorafenib resistance in Huh7 cells through HGF/c-Met/Akt and Jak2/Stat3 pathways. | 2014 |
1 |
| 21 |
25252914 | Cancer-associated adipose tissue promotes breast cancer progression by paracrine oncostatin M and Jak/STAT3 signaling. | 2014 Dec 1 |
1 |
| 22 |
22121136 | The JAK inhibitor CP-690,550 (tofacitinib) inhibits TNF-induced chemokine expression in fibroblast-like synoviocytes: autocrine role of type I interferon. | 2012 Mar |
1 |
| 23 |
22252297 | Low dose CP-690,550 (tofacitinib), a pan-JAK inhibitor, accelerates the onset of experimental autoimmune encephalomyelitis by potentiating Th17 differentiation. | 2012 Feb 10 |
1 |
| 24 |
22348037 | EGCG enhances the therapeutic potential of gemcitabine and CP690550 by inhibiting STAT3 signaling pathway in human pancreatic cancer. | 2012 |
2 |